Cargando…
Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052546/ https://www.ncbi.nlm.nih.gov/pubmed/30038798 http://dx.doi.org/10.1186/s40900-018-0109-z |
_version_ | 1783340676349427712 |
---|---|
author | Selby, Peter Velikova, Galina |
author_facet | Selby, Peter Velikova, Galina |
author_sort | Selby, Peter |
collection | PubMed |
description | PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures or PROMs) which ask about clinical issues (such as disease symptoms or treatment side-effects) as well as social, emotional and psychological issues has existed for 40 years. They provide a powerful way of working out whether an aspect of diagnosis or treatment for cancer is bringing real benefits to patients that can be measured using these structured questionnaires. When they are used, studies and cancer service developments are clearly constrained to focus on what matters to patients rather than, perhaps what matters to health service professionals or recent exciting but perhaps relatively unproven new technologies. There is good evidence that PROMs can contribute valuable inputs into the results of randomised controlled trials, clinical consultations and surveys of whole populations even at a national level. However, there is a great deal more work to be done on methodology and perhaps to change attitudes and cultures within the healthcare professions before they can deliver all of their potential to bring benefits to cancer patients. ABSTRACT: In response to Roger Wilson’s challenge to place a patient-centred approach using Patient Reported Outcome Measures (PROMs) across all of the patient pathway, we have summarised progress over 40 years. We have critically evaluated what has been achieved to use patient reported outcomes in randomised controlled trials, in routine clinical practice and in population surveys. We conclude that there has been substantial scientific progress but that it has, arguably, been relatively slow. Barriers to placing PROMs centre stage in all of these areas of activity remain in methodology and to a degree in professional attitudes and culture. Active research programmes on methodology and closer working between healthcare professionals, cancer patients and patient advocates are the key requirements to speed up the use and application of PROMs and which should bring benefits to cancer patients and healthcare services. |
format | Online Article Text |
id | pubmed-6052546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60525462018-07-23 Taking patient reported outcomes centre stage in cancer research – why has it taken so long? Selby, Peter Velikova, Galina Res Involv Engagem Letter PLAIN ENGLISH SUMMARY: Roger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures or PROMs) which ask about clinical issues (such as disease symptoms or treatment side-effects) as well as social, emotional and psychological issues has existed for 40 years. They provide a powerful way of working out whether an aspect of diagnosis or treatment for cancer is bringing real benefits to patients that can be measured using these structured questionnaires. When they are used, studies and cancer service developments are clearly constrained to focus on what matters to patients rather than, perhaps what matters to health service professionals or recent exciting but perhaps relatively unproven new technologies. There is good evidence that PROMs can contribute valuable inputs into the results of randomised controlled trials, clinical consultations and surveys of whole populations even at a national level. However, there is a great deal more work to be done on methodology and perhaps to change attitudes and cultures within the healthcare professions before they can deliver all of their potential to bring benefits to cancer patients. ABSTRACT: In response to Roger Wilson’s challenge to place a patient-centred approach using Patient Reported Outcome Measures (PROMs) across all of the patient pathway, we have summarised progress over 40 years. We have critically evaluated what has been achieved to use patient reported outcomes in randomised controlled trials, in routine clinical practice and in population surveys. We conclude that there has been substantial scientific progress but that it has, arguably, been relatively slow. Barriers to placing PROMs centre stage in all of these areas of activity remain in methodology and to a degree in professional attitudes and culture. Active research programmes on methodology and closer working between healthcare professionals, cancer patients and patient advocates are the key requirements to speed up the use and application of PROMs and which should bring benefits to cancer patients and healthcare services. BioMed Central 2018-07-19 /pmc/articles/PMC6052546/ /pubmed/30038798 http://dx.doi.org/10.1186/s40900-018-0109-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter Selby, Peter Velikova, Galina Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title | Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title_full | Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title_fullStr | Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title_full_unstemmed | Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title_short | Taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
title_sort | taking patient reported outcomes centre stage in cancer research – why has it taken so long? |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052546/ https://www.ncbi.nlm.nih.gov/pubmed/30038798 http://dx.doi.org/10.1186/s40900-018-0109-z |
work_keys_str_mv | AT selbypeter takingpatientreportedoutcomescentrestageincancerresearchwhyhasittakensolong AT velikovagalina takingpatientreportedoutcomescentrestageincancerresearchwhyhasittakensolong |